COMPANY
ALLInBio
ALLInBio's website says: “ALLInBio is developing a precision immunology approach that allows the selection and early treatment of "at-risk" patient populations that are genetically predisposed to rapidly progress and develop severe disease.” From company website Source · Oct 12, 2026